The pharma executive is optimistic about the new US administration but is also realistic about the risks that come with "radical change." ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

However, Pfizer's revenue guidance for 2025 doesn't look particularly exciting. The company expects its top line to come in ...

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...

R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the ...

Additionally, FPT’s digital transformation solution for Long Chau Pharmacy has enhanced the customer experience by enabling ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

It's been about five years since the first case of COVID-19 was confirmed in Australia. This is what Australia living through "unprecedented times" looks like in numbers.

The Pharmaceutical Technology Excellence Awards winners have been announced! Download our full 50+ page report to find out ...

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...